Kinnovata Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Kinnovata General Information
Description
Developer and manufacturer of respiratory products focused on the domestic Chinese and other regional markets in Asia. The company offers services catering to the development, production and commercialization of products addressing needs in Asian asthma and chronic obstructive pulmonary disease (COPD) markets.
Contact Information
Corporate Office
- Tianjin
- China
Corporate Office
- Tianjin
- China
Kinnovata Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kinnovata Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kinnovata FAQs
-
When was Kinnovata founded?
Kinnovata was founded in 2017.
-
Where is Kinnovata headquartered?
Kinnovata is headquartered in Tianjin, China.
-
What industry is Kinnovata in?
Kinnovata’s primary industry is Drug Discovery.
-
Is Kinnovata a private or public company?
Kinnovata is a Private company.
-
What is Kinnovata’s current revenue?
The current revenue for Kinnovata is .
-
Who are Kinnovata’s investors?
Tianjin Kingyork Group, Vectura Group, and Zendex Bio Strategy have invested in Kinnovata.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
